Resonance Health Expands TrialsWest Business in Western Australia, Shares Rise 8%
MT Newswires Live
Jul 08
Resonance Health (ASX:RHT) said it will expand its TrialsWest business with a third trial site in Mandurah, Western Australia, which is expected to open in August, according to a Tuesday Australian bourse filing.
The new site is located around 60 kilometers from the nearest TrialsWest site located in the Perth suburb of Spearwood, and it will allow the firm to capitalize on its existing clinical trial workflows, including the pharmaceutical clinical trials being managed by the group.
Further new sites will be targeted in coming periods, the filing added.
Its shares rose 8% in recent trading on Tuesday.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.